Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medial temporal lobe atrophy in memory disorders

F Pasquier1, M Hamon, F Lebert

  • 1Department of Neurology, University Hospital, Lille, France.

Journal of Neurology
|March 1, 1997
PubMed
Summary

Medial temporal lobe atrophy on CT scans can help diagnose Alzheimer's disease (AD). Measuring the medial temporal lobe width accurately identifies AD patients, aiding early diagnosis in memory clinics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The pattern of cortical thickness associated with executive dysfunction in MCI and SCC: The MEMENTO cohort.

Revue neurologique·2024
Same author

Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical Trials.

The journal of prevention of Alzheimer's disease..·2024
Same author

Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Exploring diastolic pressure ratio to fractional flow reserve discordance and a hypothesis on tailoring diastolic pressure ratio cut-off values to improve diagnostic accuracy in the mid- and distal-LAD.

International journal of cardiology. Heart & vasculature·2021
Same author

Effects of azacitidine in 93 patients with <i>IDH1/2</i> mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study.

Leukemia & lymphoma·2020
Same author

Urticaria (angioedema) and COVID-19 infection.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020

Area of Science:

  • Neurology
  • Radiology
  • Geriatrics

Background:

  • Medial temporal lobe atrophy is a known indicator of Alzheimer's disease (AD).
  • Early and accurate diagnosis of AD is crucial for effective patient management.
  • Temporal lobe oriented computed tomography (CT) offers a potential method for assessing this atrophy.

Purpose of the Study:

  • To evaluate the diagnostic accuracy of medial temporal lobe measurements using CT.
  • To assess the utility of this method for diagnosing AD, particularly in early stages.
  • To determine the optimal cut-off for medial temporal lobe width in AD diagnosis.

Main Methods:

  • A total of 333 patients from a Memory Disorders Clinic were included.
  • Patients were categorized into probable AD, possible AD, miscellaneous memory disorders, anxious/depressed, and controls.

Related Experiment Videos

  • Minimum medial temporal lobe width was measured using temporal lobe oriented CT scans.
  • Main Results:

    • A cut-off of 11.5 mm best distinguished AD patients from non-AD patients.
    • The measurement showed a sensitivity of 0.81 and specificity of 0.95 for probable AD.
    • Diagnostic accuracy for probable AD was 0.83, with a high positive predictive value (0.99).

    Conclusions:

    • Temporal lobe oriented CT measurement of medial temporal lobe atrophy is a valuable tool for AD diagnosis.
    • This method demonstrates high accuracy and specificity, supporting its use in routine clinical practice.
    • The findings suggest its utility for assessing AD, especially in early disease stages.